share_log

大幸薬品:2024年第2四半期の決算の要約

Taiko Pharmaceutical: Summary of the Q2 2024 financial statements.

JPX ·  Aug 9 14:30

The translation is provided by third-party software.


The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.